Recurrent Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor
specificThe reemergence of ovarian malignant mixed mesodermal (Mullerian) tumor after a period of remission.
8
Centers
8
Active Trials
—
Cancer Funding
Top Centers for Recurrent Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 56.2 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 56.2 |
| 3 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 56.2 |
| 4 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 56.2 |
| 5 | NCI Comprehensive Active Research Program | 56.2 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.2 |
| 7 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 56.2 |
| 8 | Boston University Cancer CenterBoston, MA Active Research Program | 56.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →